Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Engage Bio
AddedFeb 17, 2024
UpdatedJul 3, 2026
Engage Bio

Engage Bio

Acquired

Engage Bio: Pioneering mRNA treatments to target and eliminate cancer.

HQ
San Carlos, CA, US
Founded
2021
Accelerator
Y Combinator logoY CombinatorW22
Overview
Compare
Fundraising
Employees

Engage Bio, founded by experts in immunotherapy and mRNA therapeutics, is committed to developing mRNA immunotherapies to combat cancer. The company focuses on transforming cancer cells into factories for therapeutic proteins, enabling localized treatment that targets tumors while sparing healthy tissues. Engage Bio's innovative approach aims to provide effective cancer treatment with minimal side effects, positioning it at the forefront of oncology therapeutics.

Notable figures affiliated with Engage Bio include its founders, who have a proven track record with four drugs already in clinical trials. The company has attracted significant interest from investors due to its pioneering technology and potential for high impact in cancer treatment. Engage Bio's achievements in advancing mRNA therapies underscore its potential to revolutionize cancer care, making a significant impact on patient outcomes and the broader medical community.

Engage Bio - Similar Companies

Sensible Biotechnologies logo

Sensible Biotechnologies

sensible.bio

Asher Bio logo

Asher Bio

asherbio.com

Rnaimmune logo

Rnaimmune

rnaimmune.com

Cisterna Biologics logo

Cisterna Biologics

cisternabx.com

Guardian Bio logo

Guardian Bio

guardian-bio.com

Kernal Biologics logo

Kernal Biologics

kernalbio.com

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

ParcelBio logo

ParcelBio

parcelbio.com

Cartography Biosciences logo

Cartography Biosciences

cartography.bio

Eugit Therapeutics logo

Eugit Therapeutics

Excepgen logo

Excepgen

excepgen.com

Manhattan BioSolutions logo

Manhattan BioSolutions

Endpoint Health logo

Endpoint Health

ManaT Bio logo

ManaT Bio

clasptx.com

Serinus Biosciences logo

Serinus Biosciences

serinus.bio

Engage Bio - Quick Facts

Who are Engage Bio's competitors?

Companies similar to Engage Bio include Sensible Biotechnologies, Asher Bio, Rnaimmune and Cisterna Biologics.

When was Engage Bio founded?

Engage Bio was founded in 2021.

Where is Engage Bio's headquarters located?

Engage Bio's headquarters is located in San Carlos, CA, US.

When was Engage Bio's last funding round?

Engage Bio's most recent funding round was for $3.9M (USD) in May 2022.

How much has Engage Bio raised to-date?

As of May 1, 2022, Engage Bio has raised a total of $3.9M (USD).

Engage Bio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • mRNA
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Cancer Treatment
  • Immunotherapy
Tags
  • Consulting
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research